Related Experiment Video
Updated: Jul 30, 2026
10:58
PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions
Published on: July 27, 2017
PI 3-kinase: structural and functional analysis of intersubunit interactions
The EMBO Journal
|February 1, 1994
Summary
Researchers identified specific binding sites between the p85 regulatory subunit and the p110 catalytic subunit of phosphatidylinositol 3-kinase (PI 3-kinase). This interaction is crucial for PI 3-kinase complex formation and regulation.
Area of Science:
- Molecular Biology
- Cell Signaling
- Protein Interactions
Background:
- Phosphatidylinositol 3-kinase (PI 3-kinase) is a critical enzyme in cellular signaling pathways.
- PI 3-kinase comprises regulatory (p85) and catalytic (p110) subunits.
- The p85 subunit contains SH2 domains that mediate interactions with activated tyrosine kinase receptors.
Purpose of the Study:
- To elucidate the molecular basis of the interaction between p85 and p110 subunits of PI 3-kinase.
- To identify the specific amino acid regions responsible for mediating this intersubunit binding.
- To understand the structural implications of this interaction for PI 3-kinase regulation.
Main Methods:
- Utilized glutathione S-transferase (GST) fusion proteins to map binding sites on the p85 subunit.
- Employed deletion mutants of the p85 inter-SH2 region to define the minimal binding sequence.
- Performed transient expression of mutant p85 alpha in mouse L cells to assess in vivo binding.
- Mapped the complementary interaction site on the N-terminal region of the p110 subunit.
Main Results:
- Identified a 104-amino acid region within the p85 inter-SH2 domain that directly binds p110.
- Further refined the p85 binding site to a 35-amino acid sequence.
- Demonstrated that a mutant p85 alpha lacking this binding region cannot associate with PI 3-kinase activity in vivo.
- Localized the p110 binding site to an 88-amino acid region in its N-terminus, mediating interaction with both p85 alpha and p85 beta.
- Predicted a coiled-coil structure for the p85 inter-SH2 region.
Conclusions:
- The inter-SH2 region of p85 is a key module for binding the p110 catalytic subunit.
- Specific amino acid sequences within p85 and p110 mediate their stable complex formation.
- The structural prediction of the p85 inter-SH2 region provides insight into subunit interactions.
- Understanding these interactions is vital for comprehending PI 3-kinase complex regulation and function.
Related Concept Videos
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:35Disassembly of Intermediate Filaments
Intermediate filaments (IFs) do not undergo spontaneous disassembly. Enzymes, kinases, and phosphatases add and remove phosphates from specific sites to regulate their disassembly. The IF concentration in the cytoplasm also regulates the disassembly. If the concentration crosses a threshold, it activates the protein kinases in the vicinity, allowing the phosphorylation of IFs.
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
01:30Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...